Genetic biomarker may help identify neuroblastomas vulnerable to novel class of drugs




An irregularity within many neuroblastoma cells may indicate whether the tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors

Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/X...

Martes, 9 de Abril 2013
Jueves, 1 de Enero 1970
1

1 1
Otros artículos de esta sección